Aclarion revises CLARITY trial criteria after missing Q4 enrollment goal

October 8, 2026 7:01 AM

Aclarion, Inc. (Nasdaq: ACON, ACONW) announced it has broadened the enrollment criteria for its pivotal CLARITY clinical trial after enrollment ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found